NAD+ repletion attenuates obesity‐induced oocyte mitochondrial dysfunction and offspring metabolic abnormalities via a SIRT3‐dependent pathway
Open Access
- 19 December 2021
- journal article
- letter
- Published by Wiley in Clinical and Translational Medicine
- Vol. 11 (12) , e628
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (31970800)
This publication has 9 references indexed in Scilit:
- NAD+ metabolism: pathophysiologic mechanisms and therapeutic potentialSignal Transduction and Targeted Therapy, 2020
- Obesity induces ovarian inflammation and reduces oocyte qualityReproduction, 2019
- NAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NRCell Metabolism, 2018
- Sirt3-dependent deacetylation of SOD2 plays a protective role against oxidative stress in oocytes from diabetic miceCell Cycle, 2017
- Slowing ageing by design: the rise of NAD+ and sirtuin-activating compoundsNature Reviews Molecular Cell Biology, 2016
- Effects of Maternal Obesity on Fetal Programming: Molecular ApproachesCold Spring Harbor Perspectives in Medicine, 2015
- Maternal obesity in females born small: Pregnancy complications and offspring disease riskMolecular Nutrition & Food Research, 2015
- Impact of Maternal Obesity on Fetal HealthFetal Diagnosis and Therapy, 2013
- SIRT3 Is a Mitochondria-Localized Tumor Suppressor Required for Maintenance of Mitochondrial Integrity and Metabolism during StressCancer Cell, 2010